DUSP4 and hepatocellular carcinoma: Through the application of genome-wide CRISPR/Cas9 library screening, Huang et al. have identified DUSP4 as the crucial gene associated with the emergence of resistance to Lenvatinib in hepatocellular carcinoma (HCC).